Literature DB >> 32175251

Modern surgery for advanced thyroid cancer: a tailored approach.

Marika D Russell1, Dipti Kamani2, Gregory W Randolph2,3.   

Abstract

Surgical treatment of advanced thyroid malignancy can be morbid, compromising normal functions of the upper aerodigestive tract. There is a paucity of guidelines dedicated to the management of advanced disease. In fact, there is not even a uniform definition for advanced thyroid cancer currently. The presence of local invasion, bulky cervical nodes, distant metastases or recurrent disease should prompt careful preoperative evaluation and planning. Surgical strategy should evolve from multidisciplinary discussion that integrates individual disease characteristics and patient preference. Intraoperative neuromonitoring has important applications in surgery for advanced disease and should be used to guide surgical strategy and intraoperative decision-making. Recent paradigm shifts, including staged surgery and use of neoadjuvant targeted therapy hold potential for decreasing surgical morbidity and improving clinical outcomes. Modern surgical planning provides optimal treatment for each patient through a tailored approach based on exact extent and type of disease as well as incorporating appreciation of surgical complications, patient preferences and intraoperative findings. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Advanced thyroid cancer; intraoperative neuromonitoring; neoadjuvant therapy; staged surgery; tailored approach

Year:  2020        PMID: 32175251      PMCID: PMC7044078          DOI: 10.21037/gs.2019.12.16

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  4 in total

Review 1.  Current practice in patients with differentiated thyroid cancer.

Authors:  Martin Schlumberger; Sophie Leboulleux
Journal:  Nat Rev Endocrinol       Date:  2020-12-18       Impact factor: 43.330

2.  Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma.

Authors:  Wei Du; Xiangyu Shi; Qigen Fang; Xu Zhang; Shanting Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

3.  Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach.

Authors:  Antonio Mario Bulfamante; Eleonora Lori; Maria Irene Bellini; Elisa Bolis; Paolo Lozza; Luca Castellani; Alberto Maria Saibene; Carlotta Pipolo; Emanuela Fuccillo; Cecilia Rosso; Giovanni Felisati; Loredana De Pasquale
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

4.  Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report.

Authors:  Yingchao Zhang; Xianzhao Deng; Zheng Ding; Jie Kang; Bo Wu; Bomin Guo; Youben Fan
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.